Large moderately-differentiated ovarian Sertoli-Leydig cell tumor in a 13-year-old female: A case report

Zhang,Hui; Hao,Jing; Li,Chun‑Yan; Li,Tao; Mu,Yu‑Lan

doi:10.3892/ol.2015.3979

Large moderately-differentiated ovarian Sertoli-Leydig cell tumor in a 13-year-old female: A case report

Authors:
- Hui Zhang
- Jing Hao
- Chun‑Yan Li
- Tao Li
- Yu‑Lan Mu
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250012, P.R. China, Department of Histology and Embryology, Medical School of Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: November 30, 2015 https://doi.org/10.3892/ol.2015.3979
Pages: 1110-1112

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sertoli-Leydig cell tumor of the ovary, also known as androblastoma, is a rare neoplasm from the group of sex cord‑stromal tumors of the ovary. The tumor accounts for <0.5% of all primary ovarian neoplasms. The clinical signs and symptoms of Sertoli‑Leydig cell tumors can be associated with either hormonal production or the presence of a mass‑occupying lesion. In the current study, a 13‑year‑old female was diagnosed with a stage Ⅰc ovarian Sertoli‑Leydig cell tumor following abdominal pain and distension. One month after a right oophorectomy, the follow‑up magnetic resonance imaging scan was negative for residual or recurrent tumor. The overall 5‑year survival rate for moderately‑differentiated (grade 2) and poorly‑differentiated (grade 3) Sertoli-Leydig cell tumors is 80%, and long-term follow-up is therefore highly advised in this patient.

View Figures

View References

1	Young RH and Scully RE: Ovarian Sertoli-Leydig cell tumors. Histopathology. Am J Surg Pathol. 9:543–569. 1985. View Article : Google Scholar : PubMed/NCBI
2	Abu-Zaid A, Azzam A, Alghuneim LA, Metawee MT, Amin T and Al-Hussain TO: Poorly differentiated ovarian sertoli-leydig cell tumor in a 16-year-old single woman A case report and literature review. Case Rep Obstet Gynecol. 2013:8585012013.PubMed/NCBI
3	Weng CS, Chen MY, Wang TY, Tsai HW, Hung YC, Yu KJ, Chiang YC, Lin H, Lu CH and Chou HH: Sertoli-Leydig cell tumors of the ovary, A Taiwanese Gynecologic Oncology Group study. Taiwan J Obstet Gynecol. 52:66–70. 2013. View Article : Google Scholar : PubMed/NCBI
4	Bhat RA, Lim YK, Chia YN and Yam KL: Sertoli-Leydig cell tumor of the ovary, Analysis of a single institution database. J Obstet Gynecol Res. 39:305–310. 2013. View Article : Google Scholar
5	FIGO Committee on Gynecologic Oncology, Current FIGO staging for cancer of the vagina fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet. 105:3–4. 2009. View Article : Google Scholar : PubMed/NCBI
6	Garzo VG and Dorrington JH: Aromatase activity in human granulosa cellsduring follicular development and the modulation by follicle-stimulatinghormone and insulin. Am J Obstet Gynecol. 148:657–662. 1984. View Article : Google Scholar : PubMed/NCBI
7	Rossing M, Gerdes AM, Juul A, Rechnitzer C, Rudnicki M, Nielsen FC and Vo Hansen T: A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter. A case report. J Med Case Rep. 8:1122014. View Article : Google Scholar : PubMed/NCBI
8	Moghazy D, Sharan C, Nair M, Rackauskas C, Burnette R, Diamond M, Al-Hendy O and Al-Hendy A: Sertoli-Leydig cell tumor with unique nail findings in a post-menopausal woman A case report and literature review. J Ovarian Res. 7:832014. View Article : Google Scholar : PubMed/NCBI
9	Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, et al: DICER1 mutations in familial pleuropulmonary blastoma. Science. 325:9652009. View Article : Google Scholar : PubMed/NCBI
10	Frio Rio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, SabbaghianN, Pouchet C, Gilbert L, O'Brien PK, Serfas K, et al: DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 305:68–77. 2011. View Article : Google Scholar : PubMed/NCBI
11	Dehner LP, Jarzembowski JA and Hill DA: Embryonal rhabdomyosarcoma of the uterine cervix, A report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol. 25:602–614. 2012. View Article : Google Scholar : PubMed/NCBI
12	Zaloudek C and Norris HJ: Sertoli-Leydig tumors of the ovary. Histopathology. Am J Surg Pathol. 8:405–418. 1984. View Article : Google Scholar : PubMed/NCBI
13	Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF and Woodcock AS: Sertoli-Leydig cell tumors, A clinicopathologic study of 34 cases. Cancer. 48:187–197. 1981. View Article : Google Scholar : PubMed/NCBI
14	Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M and Mangili G: Ovarian Sertoli-Leydig cell tumors. Histopathology. Gynecol Oncol. 125:673–676. 2012. View Article : Google Scholar : PubMed/NCBI